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        The adaptive eff  ector CD4  Th-mediated im-
m  une response is highly heterogenous, based 
on the development of distinct subsets that 
are characterized by diff  erent profi  les of cy-
tokine production. Initially, two polarized forms 
of Th eff  ectors, type 1 (Th1) or type 2 (Th2), 
were identifi  ed in both mice and humans (  1, 2  ). 
Th1 cells produce IFN-      and are mainly de-
voted to protection against intracellular mi-
crobes, whereas Th2 cells produce IL-4, -5, -9, 
and -13 and are involved in the protection 
against gastrointestinal nematodes, but are also 
responsible for allergic disorders (  3, 4  ). A third 
type of Th that is able to produce both Th1 
and Th2 cytokines, type 0 (Th0), has also been 
detected (  5  ). More recently, a novel subset of 
Th, which is distinct from Th1, Th2, and Th0 
cells and is called Th17, has been described (  6  ). 
Th17 cells originate under diff  erent polarizing 
conditions than Th1 or Th2, which have been 
found to be the early presence at the time of 
antigen presentation to the naive Th of IL-12 
or -4, respectively (  7  ). Initial fi  ndings reported 
that, in the presence of   Borrelia burgdorferi  , IL-17 
could be produced by T cells independent 
of the production of Th1 or Th2 cytokines (  8  ). 
However, the major breakthrough leading to 
discovery of Th17 lineage came from mouse 
models of autoimmunity. Experimental auto-
im  mune encephalomyelitis (EAE) and colla-
gen-in  duced arthritis (CIA), two prototypical 
autoimmune mouse models, have historically 
been associated with unchecked Th1 responses, 
based on studies in which disease development 
was ablated by treatment with neutralizing 
anti  bodies (Ab) specifi  c for IL-12p40 or gene-
targeted mice defi  cient in the p40 subunit of 
IL-12 (  9, 10  ). However, with the discovery 
that a new IL-12 family member, IL-23, shares 
the p40 subunit with IL-12 but comprises of 
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the gut of patients with Crohn  ’  s disease. Both Th17 and Th17/Th1 clones showed selective 
expression of IL-23R, CCR6, and the transcription factor ROR    t, and they exhibited similar 
functional features, such as the ability to help B cells, low cytotoxicity, and poor suscepti-
bility to regulation by autologous regulatory T cells. Interestingly, these subsets also ex-
pressed the Th1-transcription factor T-bet, and stimulation of these cells in the presence 
of IL-12 down-regulated the expression of ROR    t and the production of IL-17, but in-
duced IFN-    . These effects were partially inhibited in presence of IL-23. Similar receptor 
expression and functional capabilities were observed in freshly derived IL-17  –  producing 
peripheral blood and tonsillar CD4 T cells. The demonstration of selective markers for 
human Th17 cells may help us to understand their pathogenic role. Moreover, the identifi  -
cation of a subset of cells sharing features of both Th1 and Th17, which can arise from the 
modulation of Th17 cells by IL-12, may raise new issues concerning developmental and/or 
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  synovial fl   uids, and synovial biopsies of most rheumatoid 
  arthritis (RA) patients, whereas both are absent in osteoar-
thritis (  24, 25  ). IL-17 has also been detected in the sera and 
diseased tissues of patients with systemic lupus erythematosus 
(  26  ), in systemic sclerosis (  27  ), and in sera and colonic biop-
sies of infl  ammatory bowel disorders (  28, 29  ), as well as in the 
aff  ected skin of subjects with nickel-induced contact derma-
titis or psoriasis (  30  ). However, all of these studies were per-
formed by assessing the presence of mRNA for IL-17 in 
tissues and/or measuring IL-17 in biological fl  uids. Only two 
reports have shown the production of IL-17 by small num-
bers of T cell clones generated from the skin of subjects with 
contact dermatitis (  30  ) or the synovial membranes and syno-
vial fl  uid of subjects with RA (  31  ); however, no additional 
information on the phenotypic and functional features of 
human IL-17  –  producing T cells were provided. 
  In this study, we demonstrate the existence of remark-
able proportions of Th17 and of IFN-       –  producing Th17 
(Th17/Th1) in the gut of subjects with Crohn  ’  s disease (CD). 
When expanded in vitro and cloned, Th17 and Th17/Th1 
clones showed selective expression of IL-23R, CCR6, and 
the transcription factor ROR     t. Both Th17 and Th17/Th1 
clones showed an excellent ability to help B cells, low cyto-
toxic potential, and reduced susceptibility to suppression by 
autologous CD4 Foxp3  regulatory T (T reg) cells. Similar 
receptor expression and functional capabilities were observed 
in IL-17  –  producing T cell clones obtained from normal gut, 
as well as in freshly derived PB and tonsillar IL-17  –  producing 
CD4  T cells. Interestingly, both Th17 and Th17/Th1 clones 
also expressed the Th1-related transcription factor T-bet, and 
their culturing in the presence of IL-12 down-regulated the 
another subunit, p19, which is diff  erent from the p35 subunit 
of IL-12 (  11  ), it was found that both EAE and CIA were 
  ablated in mice defi  cient in IL-23, but not IL-12 (  12, 13  ). 
Moreover, mice lacking the IL-12R complex also succumbed 
to EAE (  14  ), suggesting that IL-23, and not IL-12, is critically 
linked to autoimmunity, at least in these models. Although 
IL-23 appeared to be required for Th17-mediated immuno-
pathology, more recent reports indicate that it is not required 
for Th17 commitment, but instead appears to be important 
for amplifying and/or stabilizing the Th17 phenotype (  15, 16  ). 
The concomitant activity of TGF-      and IL-6 appears to be 
necessary for initiation of Th17 diff  erentiation (  17, 18  ). 
Moreover, IL-1      and TNF-      were found to amplify the 
Th17 response induced by TGF-      and IL-6, but could not 
substitute for either of these cytokines (  19  ). Finally, an analy-
sis of transcription-factor expression by IL-17  –  producing 
CD4  T cells showed that Th17 eff  ectors lacked expression 
of T-bet and Hlx in comparison to Th1-polarized cells, and 
of GATA-3 compared with Th2-polarized populations, sup-
porting and extending previous fi  ndings that identifi  ed Th17 
as a product of an eff  ector lineage distinct from Th1 and Th2 
(  20, 21  ). The latter fi  nding was supported by the recent dem-
onstration that the orphan nuclear receptor ROR     t directs 
the diff  erentiation program of mouse Th17 (  22  ). 
  Most of the knowledge of Th17 available so far originates 
from studies performed in experimental animal models, 
whereas very little information on Th17 exists in humans. 
A higher number of IL-17 mRNA  –  expressing cells were found 
by using in situ hybridization in the cerebrospinal fl  uid than in 
peripheral blood (PB) from patients with multiple sclerosis (  23  ). 
Moreover both IL-17 and -23p19 are present in the sera, 
  Figure 1.     Ex vivo identifi  cation of human Th17 and Th17/Th1. (A) CD4  T cells from PB of healthy subjects, healthy gut areas of subjects with 
colon carcinoma, and PB and disease-affected gut areas of subjects with CD were assessed by intracellular staining with fl  ow cytometry for their ability 
to produce IFN-      (black), IL-4 (gray), or IL-17 (white) after stimulation with PMA plus ionomycin. (B) Proportions of IL-17  –  producing cells able to also 
produce IFN-      (black) or IL-4 (gray) among CD4  T cells from PB or gut of subjects with CD. Columns in A and B represent mean values (      the  SEM) 
obtained from 10 different subjects for each group. a versus c, P       0.05; b versus c, P       0.05; d versus e, P       0.05. (C) Representative fl  ow cytometric 
analyses in PB and gut of one subject with CD.     JEM VOL. 204, August 6, 2007 
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with colon carcinoma or from PB of subjects with CD, whereas 
they were signifi  cantly higher in disease-aff  ected gut areas of 
the same subjects with CD (  Fig. 1 A  ).   Comparable propor-
tions of IL-17  –  producing cells were found among CD4  
T lymphocytes derived from the disease-aff  ected gut areas 
of fi  ve subjects suff  ering from ulcerative colitis (unpublished 
data). A minor, but consistent, proportion of IL-17  –  producing 
CD4  T cells derived from PB of healthy subjects or 
healthy gut areas (not depicted), as well as from PB or disease-
aff  ected gut areas of subjects with CD (  Fig. 1, B and C  ), 
also exhibited the ability to produce IFN-     , whereas cells 
producing both IL-17 and -4 were virtually undetectable. 
Notably, proportions of Th17 also producing IFN-      were 
higher among gut T cells than PB CD4  T cells from sub-
jects with CD (  Fig. 1, B and C  ). IL-17  –  producing CD4  
T cells were found to be contained within the CD45RO  
population, and they all appeared to be TCR            cells (un-
published data). 
expression of ROR     t and IL-17 and up-regulated the pro-
duction of IFN-     , suggesting that, at least in humans, a devel-
opmental and/or functional relationship between Th17 and 
Th1 may exist. 
    RESULTS   
  Ex vivo demonstration of IL-17  –  producing CD4 T cells 
in subjects with CD, and their in vitro expansion and cloning 
  The presence of IL-17  –  producing cells was evaluated by fl  ow 
cytometry on CD4  T cells from PB of 10 healthy individu-
als, as well as from PB and disease-aff  ected areas of 10 subjects 
with CD, after their stimulation with PMA and ionomycin. 
As an additional control, CD4  T cells derived from ap-
parently healthy gut areas of 10 subjects who underwent 
colectomy because of colon carcinoma were also assessed. 
Proportions of Th17 were consistently      1% in PB from 
healthy individuals, and only slightly higher among CD4  
T cells derived from apparently healthy gut areas of subjects 
  Figure 2.     Cytokine production by in vitro  –  expanded CD4 T cells from PB and gut and by T cell clones from gut of subjects with CD. 
(A) CD4  T cells from PB or disease-affected gut areas of 10 subjects with CD were stimulated for 7 d with anti-CD3 plus anti-CD28 mAb and IL-2, and 
their ability to produce IFN-      (black), IL-4 (gray), or IL-17 (white) was assessed (see   Fig. 1   legend). Columns represent the mean values (      the  SEM). 
a   versus b, P       0.05. (B) Representative fl  ow cytometric analyses on expanded PB or gut CD4  T cells from the same CD subject. (C) A total number of 217 
T cell clones (circles) were obtained from CD4  T cells of disease-affected gut areas of two subjects with CD and assessed by fl  ow cytometry for intracellular 
synthesis of IFN-     , IL-4, and IL-17 after stimulation with PMA plus ionomycin. Production of cytokines by each clone was arbitrarily considered as 
noteworthy when the proportion of producing T cell blasts was      20%. (D) Representative fl  ow cytometric analyses of cytokine production for each 
type of clone.   1852 HUMAN T  H  17 CELLS | Annunziato et al.
  Th17 and Th17/Th1 clones exhibit similar 
functional properties 
  The ability of Th17 and Th17/Th1 clones to help Ab pro-
duction by B cells and to display cytotoxic activity, as well as 
their susceptibility to the suppressive activity of an autologous 
CD4 CD25 Foxp3  T cell clone were then evaluated and 
compared with the same activities assessed on Th1 and Th2 
clones. Both Th17 and Th17/Th1 clones showed the ability 
to induce B cell production of IgM, IgG, and IgA, but not of 
IgE, with the latter appearing to be a selective property of Th2 
clones (  Fig. 5 A  ).   In regard to the cytotoxic potential, Th17, 
Th17/Th1, and, as expected, Th2 clones exhibited granzyme 
A expression at levels signifi  cantly lower than those of Th1 
clones, with the granzyme levels of Th17/Th1 clones higher 
than those present in Th17 and Th2 clones (  Fig. 5 B  ). More-
over, the cytotoxic ability of Th17 and Th17/Th1 clones 
was signifi  cantly lower than that of Th1 clones (  Fig. 5 C  ). 
Finally, the ability of Th17 and Th17/Th1 clones to prolifer-
ate in response to allogeneic stimulation in the presence of 
  To better investigate the phenotypic and functional fea-
tures of IL-17  –  producing CD4  T cells, those present in PB 
or disease-aff  ected gut areas of the 10 subjects with CD were 
expanded in vitro by stimulation for 7 d with a mixture of 
anti-CD3 and -CD28 mAb in the presence of IL-2. Under 
these conditions, remarkable proportions of CD4  T-blasts 
derived from both sources showed the ability to produce 
IL-17 after their stimulation with PMA plus ionomycin, with 
those derived from gut being signifi  cantly higher (  Fig. 2 A  ).   
Notably, in agreement with the aforementioned ex vivo 
fi  ndings, some of these cells produced both IL-17 and IFN-     . 
In contrast, virtually no CD4  T-blasts producing both 
IL-17 and -4 were observed (  Fig. 2 B  ). T-blasts from two 
randomly selected cultures derived from the disease-aff  ected 
gut of subjects with CD were cloned under conditions of 
limiting dilution and expanded in the presence of alloge-
neic irradiated feeder cells and IL-2. 217 CD4  T cell clones 
were obtained, and the cytokine production (IL-4, IFN-     , 
and IL-17) by each clone was evaluated by fl  ow cytometry 
after stimulation with PMA plus ionomycin. T cell clones 
producing IL-17 alone (  n     11), IFN-      alone (  n     72), or 
IL-4 alone (  n     7) were classifi  ed as Th17, Th1, and Th2, 
respectively, whereas those producing both IL-4 and IFN-     , 
but not IL-17 (  n     66), were classifi  ed as Th0, and those 
producing both IL-17 and IFN-      (  n     50) or both IL-17 
and -4 (  n     0) were classifi  ed as Th17/Th1 or Th17/Th2, 
respectively. 11 clones apparently did not produce any of the 
three cytokines (  Fig. 2, C and D  ). 
  Th17 and Th17/Th1 clones selectively express IL-23R 
and CCR6 
  The expression of IL-12R     2 and IL23-R in Th17 and 
Th17/Th1 clones was fi  rst examined and compared with that 
found in the other types of T cell clones. IL-12R     2 was ex-
pressed by all types of clones (  Fig. 3 A  ), whereas IL-23R ap-
peared to be selectively expressed by Th17 and Th17/Th1 
clones (  Fig. 3 B  ).   However, this receptor was apparently not 
involved in Th17 or Th17/Th1 cell proliferation because   
IL-23 did not exert any proliferative activity on both types of 
clones (not depicted), even after their stimulation with anti-
CD3 plus anti-CD28 Ab (  Fig. 3 C  ). In contrast, the addition 
of IL-2, IL-12, and mainly of IL-15, potentiated the anti-
CD3/28 Ab induced proliferation of both Th17 and Th17/
Th1 clones (  Fig. 3 C  ). Among chemokine R, a high expres-
sion of CXCR4 and CXCR6 by Th17 and Th17/Th1 clones 
was shared with Th1 or Th2 clones (unpublished data). Sig-
nifi  cantly higher levels of CCR4 (  Fig. 4 A  ) and CCR5 (  Fig. 
4 B  ) were found in Th17 clones in comparison with all other 
types of clones, whereas Th17 and Th17/Th1 apparently 
lacked CXCR3-A, CXCR3-B, CCR3, CCR8 and CCR9 
(not depicted).   In contrast, CCR6 was selectively expressed 
by both Th17 and Th17/Th1, but not by Th1, Th2 or Th0, 
clones (  Fig. 4 C  ). CCR6 expressed by Th17 clones was func-
tionally active inasmuch as its ligand, CCL20, induced calcium 
infl  ux in Th17, but not in Th1, clones, whereas the CCR9 li-
gand, CCL25, did not exert any eff  ect (  Fig. 4 D  ). 
  Figure 3.     IL-23R and -12R     2 expression by Th17 and Th17/Th1 
clones and their role in cell proliferation. IL-12R     2 (A) and -23R (B) 
mRNA levels were measured in Th0, Th1, Th2, Th17, and Th17/Th1 clones. 
Columns represent mean values (      the SEM) obtained in 10 clones from each 
type, except Th2, where they represent 7 clones. (A) d versus a, P       0.05; 
d versus b, P   ns; d versus c, P       0.05; d versus e, P   ns; e versus a, 
P       0.05; e versus b, P   ns; e versus c, P       0.05. (B) i versus f, P       0.01; 
i versus g, P       0.05; i versus h, P       0.05; i versus l, P   ns; l versus f, 
P       0.001; l versus g, P       0.05; l versus h, P       0.05. (C) Proliferative 
  response of Th17 and Th17/Th1 clones after stimulation for 4 d with anti-
CD3 plus anti-CD28 Ab without or with the addition of IL-2 (black), IL-12 
(gray), IL-15 (white), or IL-23 (striped). Columns represent mean values 
(      the SEM) of mitogenic indexes (ratio between cpm obtained in the 
presence of anti-CD3/28 Ab with the indicated cytokine and cpm obtained 
with anti-CD3/CD28 Ab alone), obtained by testing seven clones from 
each type.     JEM VOL. 204, August 6, 2007 
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an autologous CD4 CD25  T reg cell clone was assessed. 
This clone expressed Foxp3, did not produce cytokines in 
response to stimulation with PMA plus ionomycin (  Fig. 6 A  ), 
and showed the ability to suppress the proliferative response 
of autologous CD25      T cells, as well as that of Th1 or Th2 
clones (  Fig. 6 B  ).   In contrast, Th17 and Th17/Th1 exhibited 
a signifi  cantly lower susceptibility to the suppressive activity 
of the same autologous T reg clone (  Fig. 6 B  ). 
  IL-12 down-regulates ROR    t and IL-17 expression, but 
up-regulates T-bet and IFN-     expression, in Th17 clones 
  We asked what was the relationship between Th17 and 
Th17/Th1, as both types of cells were already found ex vivo, 
and thus the latter could not result from a possible artifact 
caused by T cell culturing in vitro. To this end, we fi  rst as-
sessed the expression of T-bet, which is a transcription factor 
that has been found to be selective for Th1 in both mice and 
humans (  32  ), and of ROR     t, which is a transcription factor 
that has been found to be selective for mouse Th17 (  21  ). As 
control, the expression of GATA-3, which is a transcription 
factor selective for both mouse and human Th2 (  32  ), was 
also assessed. As expected, Th2 clones selectively expressed 
GATA-3 and Th1 clones selectively expressed T-bet. In con-
trast, both Th17 and Th17/Th1 clones were found to ex-
press either ROR     t or T-bet (  Fig. 7, A  –  C  ).   The presence of 
ROR     t and T-bet proteins in Th17 clones was then assessed 
by confocal microscopy. Whereas ROR     t was expressed in 
Th17, but not in Th1, clones (  Fig. 7 D  ), T-bet protein could 
be detected in both Th1 and Th17 clones (  Fig. 7 E  ). 
  Therefore, we asked whether Th17/Th1 could derive 
from each of the single Th1 or Th17 subset under particular 
environmental conditions. To answer this question, Th1 and 
Th17 clones were stimulated with anti-CD3 plus anti-CD28 
Ab and IL-2 in the absence or presence of IL-12, and the ex-
pression of ROR     t and T-bet, as well as the cytokine pro-
duction profi  le, of these clones were evaluated after 7 d of 
culture. IL-12 down-regulated ROR     t and up-regulated 
T-bet mRNA levels (  Fig. 8 A  ), and induced a signifi  cant 
increase of IFN-      and a reduction of IL-17, as shown by 
measuring cytokine mRNA levels (  Fig. 8 B  ), cytokine con-
centrations into cell-free supernatants by ELISA (  Fig. 8 C  ), 
or the proportions of IFN-       –   and IL-17  –  producing cells by 
fl  ow cytometry after stimulation with PMA plus ionomycin 
(  Fig. 8, D and E  ).   We fi  nally asked whether the IL-12  – 
induced eff  ects on cytokine production on Th17 could be 
infl  uenced by the presence of IL-23. To this end, three Th17 
and three Th1 clones were stimulated for 7 d with anti-
CD3/28 Ab and IL-2 in presence of IL-12, -23, or -12 plus -23. 
The addition of IL-12 strongly increased the concentrations    Figure 4.     Selective expression of functionally active CCR6 by Th17 
and Th17/Th1 clones. CCR4 (A), CCR5 (B), and CCR6 (C) mRNA levels in 
Th0, Th1, Th2, Th17, and Th17/Th1 clones. Columns represent mean values 
(      the SEM) obtained in 10 clones from each type, except Th2, where 
they represent 7 clones. (A) d versus a, P       0.005; d versus b, P       0.05; 
d versus c, P       0.05; d versus e, P       0.005; e versus a, P   ns; e versus b, 
P   ns; e versus c, P   ns. (B) d versus a, P       0.001; d versus b, P       0.05; 
d versus c, P       0.05; d versus e, P       0.01; e versus a, P       0.05; e versus b, 
P   ns; e versus c, P   ns. (C) d versus a, P       0.0001; d versus b, P       0.001; 
d versus  c, P       0.001; d versus e, P   ns; e versus a, P       0.05; 
e versus b, P       0.05; e versus c, P       0.05. (D) Cells from one Th17 and one 
Th1 clone were incubated with Fluo-4 and stimulated with medium alone, 
the CCR6 ligand, CCL20, the CCR9 ligand, CCL25, or ionomycin. Similar 
results were obtained with other two Th17 and three Th17/Th1 clones.     1854 HUMAN T  H  17 CELLS | Annunziato et al.
proportions of Th17 clonal cells that acquired the ability to 
produce IFN-      in response to IL-12, and their degree of 
proliferation (  Fig. 9 B  ). 
  Receptor expression and functional properties of Th17 
clones derived from CD patients are shared by Th17 clones 
from normal gut and by freshly derived Th17 cells 
  Because the majority of experiments were performed on 
T cell clones derived from disease-aff  ected areas of gut from 
patients with CD, we asked whether the observed pheno-
typic and functional features of Th17 cells were particular to 
the disease or whether they were shared by T cell clones 
derived from normal gut. As shown in   Fig. 10 A  , Th17 
and Th17/Th1 clones derived under the same experimental 
conditions from normal gut showed nearly selective CCR6, 
IL-23R, and ROR     t expression.   Despite exhibiting IL-23R, 
even these clones did not proliferate in response to IL-23, 
both in the absence or presence of anti-CD3/CD28 Ab (un-
published data). Moreover, they displayed excellent B cell 
helper ability for IgM, IgG, and IgA, but not IgE, production 
and reduced cytolytic capacity, as Th17 clones derived from 
diseased areas of subjects with CD (unpublished data). 
  We fi  nally asked whether the phenotypic and functional 
features of Th17 clones resulted from an artifact introduced 
by the cloning procedures or they were also shared by freshly 
derived Th17 cells. The ex vivo existence of T cells able to 
produce both IL-17 and IFN-     , in addition to those able to 
produce IL-17 alone, has already been shown in   Fig. 1  . How-
ever, in subsequent experiments, we assessed the presence of 
Th17 cells in human PB and tonsil CD4  T cell suspensions 
by taking advantage of the observation performed on Th17 
clones of their apparently selective expression of CCR6. A 
small, but consistently detectable, number of CCR6  CD4  
T cells was observed in both human PB and tonsils by fl  ow 
cytometry. CCR6  and CCR6      CD4  T cells were then 
separated by immunomagnetic cell sorting and assessed for 
their ability to produce IL-17 and IFN-      in response to 
of IFN-      into cell-free supernatants of Th17 clones, and even 
more into those of Th1 clones (  Figs. 8 C and 9 A  ), whereas 
the addition of IL-23 alone did not exhibit any eff  ect on 
IFN-      production by either Th17 or Th1 clones (  Fig. 9 A  ).   
However, the addition of IL-23 partially reduced the IL-12  –
  induced increase in the production of IFN-      (  Fig. 9 A  ), the 
  Figure 5.     B cell helper ability and cytotoxic potential by Th17 and Th17/Th1 clones. (A) Measurement by ELISA of IgM, IgG, IgA, and IgE levels in 
supernatants of B cells cocultured for 7 d with autologous anti-CD3 Ab-stimulated Th1, Th2, Th17, or Th17/Th1 clones. Columns represent mean values 
(      the SEM) of fi  ve different clones from each group. b   versus   a, P       0.05; c   versus   a, P       0.05; b versus c, P   ns. (B) Granzyme A expression by different 
types of clones, as assessed by fl  ow cytometry. Columns represent mean values (      the SEM) obtained with seven different clones of each type. c versus a, 
P       0.005; c versus b, P   ns; c versus d, P       0.05; d versus a, P       0.01; d versus b, P   ns. (C) Cytotoxic activity by different types of clones, as assessed 
by detection of AnnexinV binding on target cells P815 with fl  ow cytometry. Columns represent mean values (      the SEM) obtained with six different clones 
from each group. c versus a, P       0.01; c versus b, P   ns; c versus d, P       0.05; d versus a, P       0.05; d versus b, P    ns.   
  Figure 6.     Low susceptibility of Th17 and Th17/Th1 clones to the 
suppressive activity of an autologous T reg cell clone. (A) Foxp3 and 
CD25 expression by the T reg cell clone (left) and its inability to produce 
IL-4 and IFN-      in response to PMA plus ionomycin (right), as detected by 
fl  ow cytometry. (B) Suppression by the T reg cell clone of the proliferative 
response of autologous CD4 CD25      T cells stimulated with allogeneic 
irradiated PBMC, as well as of an autologous Th1 or Th2, but not Th17 or 
Th17/Th1, clone. Columns represent mean values (  ±   the SEM) of percent-
age of inhibition of the proliferative response in triplicate determinations.     JEM VOL. 204, August 6, 2007 
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least in mice, Th17 cells arise as a part of mucosal host defense 
and their major role seems to be protection against infections 
sustained by extracellular bacteria (  33  –  35  ), but under certain 
circumstances they can also be involved in the pathogenesis 
of chronic infl  ammatory disorders, including some models of 
autoimmune diseases (  9  –  14  ). Notably, in these models, IFN-      
produced by Th1 cells, which are crucial for the protection 
against intracellular bacteria, does not appear to be patho-
genic, but instead appears protective, as inhibition of IFN-      
signaling enhances the development of pathogenic Th17 and 
exacerbates autoimmunity (  20  ). Even the neutralization of IL-4 
produced by Th2 is critical in neutralizing the development of 
IL-17; however, neither IFN-      nor IL-4 seem to be eff  ective 
on already established Th17 (  20  ). 
  Currently, very little is known about human Th17. Some 
studies have shown that the presence of IL-17 mRNA or IL-17 
protein in tissues or biological fl  uids of subjects with diff  erent 
autoimmune disorders (  23  –  27  ) or other chronic infl  amma-
tory diseases (  28  –  30  ). The results of this study provide evi-
dence of the existence of increased numbers of CD4  T cells 
producing IL-17 in the disease-aff  ected gut areas of subjects 
with CD, compared with either PB or apparently healthy gut 
areas. Based on this fi  nding, IL-17  –  producing CD4  T cells 
derived from the gut of CD subjects were expanded in vitro 
and cloned to get an amount of these cells suitable for pheno-
typic and functional investigations. 
  The fi  rst information produced by our study was that a 
remarkable proportion of IL-17  –  producing CD4  T cells 
stimulation with PMA plus ionomycin. Cell sorting enabled 
a strong enrichment for CCR6  T cells (consistently      90%), 
whereas virtually no CCR6  cells were detected in the 
CCR6-depleted CD4  T cell population (unpublished data). 
Notably, all T cells producing IL-17 alone or IL-17 plus IFN-     
in response to PMA plus ionomycin were contained within 
the CCR6-enriched population, whereas CCR6-depleted T 
cells could be induced to produce IFN-     , but not IL-17 (  Fig. 
10 B  , top). Moreover, IL-23R and ROR     t mRNA levels in 
CCR6-enriched and -depleted T cells were measured. Levels 
of both IL-23R and ROR     t mRNA were found to be sig-
nifi  cantly higher in the CCR6-enriched than in the CCR6-
depleted population from either PB or tonsils (  Fig. 10 B  , 
bottom). Again, despite the presence of IL-23R, even freshly 
derived IL-17  –  producing CD4  T cells did not proliferate 
in response to IL-23, both in the absence or presence of anti-
CD3/CD28 mAbs (unpublished data). 
    DISCUSSION   
  Several studies demonstrate the existence in experimental an-
imal models of a novel subset of Th eff  ectors that are distinct 
from the classic Th1 and Th2, and that have been named 
Th17 because of their ability to produce IL-17. These cells 
represent a distinct lineage that originates mainly in the pres-
ence of TGF-      and IL-6 and need the presence of IL-23 for 
their expansion and/or maintenance. IL-23 is a member of 
the IL-12 cytokine family, which shares the p40 subunit with 
IL-12 and diff  ers in the expression of p19 instead of p35. At 
  Figure 7.     Expression of T-bet and ROR    t by Th17 and Th17/Th1 clones. ROR     t (A), T-bet (B), and GATA-3 (C) mRNA levels were measured in Th0, 
Th1, Th2, Th17, and Th17/Th1 clones. Columns represent mean values (      the SEM) in 10 clones from each type, except Th2, where they represent 7 clones. 
(A) d versus a, P       0.0001; d versus b, P       0.005; d versus c, P       0.05; d versus e, P   ns; e versus a, P       0.001; e versus b, P       0.01; e versus c, P       0.05. 
(B) d versus a, P   ns; d versus b, P   ns; d versus c, P       0.05; d versus e, P   ns; e versus a, P   ns; e versus b, P   ns; e versus c, P   ns; b versus c, 
P       0.05. (C) d versus a, P   ns; d versus b, P   ns; d versus c, P       0.05; e versus a, P       0.001; e versus b, P   ns; e versus c, P       0.001; b versus c, 
P       0.001. ROR     t (D) and T-bet (E) protein expression, as assessed by confocal microscopy. Data from one Th17 and one Th1 clone are reported. Similar 
pictures were obtained in other two Th17 and two Th1 clones. Bars, 10      m. TO-PRO-3 (red) was used to counterstain the nuclei.     1856 HUMAN T  H  17 CELLS | Annunziato et al.
gut mucosa and to get Th17 clones, is apparently at variance 
with recent results showing that IL-2 constrains generation 
of mouse Th17 cells (  36  ). The reason for such a discrepancy 
is presently not clear. Among chemokine R, both Th17 and 
Th17/Th1 clones apparently lacked CXCR3-A, CXCR3-B, 
CCR3, CCR8, and CCR9, but exhibited high levels of 
CXCR4 and CXCR6. Th17 clones also expressed signif-
icantly higher levels of CCR4 and CCR5 than the other 
types of clones, and both Th17 and Th17/Th1 selectively 
expressed CCR6. CCR4 expression has been associated with 
the ability of cells to traffi   c into peripheral tissues (  37  ). CCR6 
has been found to be expressed by B cells, DCs, and memory, 
but not naive, T cells. However, its ligand, MIP-3     /CCL20 
does not exert chemotactic activity on B cells, but only on 
memory T cells (  38  ). Interestingly, however, CCR6 expres-
sion by memory T cells is lost after their prolonged TCR 
triggering (  39  ). Thus, the selective expression of CCR6 by 
Th17 and Th17/Th1, but not by Th1, Th2, or Th0, clones 
may mean that Th17 and Th17/Th1 are the only memory 
T cells that continue to express CCR6 even after prolonged 
antigen activation, thereby maintaining the possibility of 
recruitment in response to MIP-3     /CCL20. This fi  nding may 
share the ability to produce IFN-     , whereas CD4  T cells 
producing both IL-17 and -4 were never observed. The cells 
producing both IL-17 and IFN-     , which we named Th17/
Th1, were not the result of an in vitro artifact, as about one 
third of ex vivo  –  derived IL-17  –  producing CD4  T cells 
already showed a double IL-17 IFN-       phenotype. When 
examined at clonal level, Th17 and Th17/Th1 shared dif-
ferent phenotypic properties from the other types of clones, 
some of which appearing to be selective. For example, only 
Th17 and Th17/Th1 clones exhibited the expression of 
IL-23R. Interestingly, the IL-23R did not apparently play any 
role in the expansion of these cell subsets, because they did 
not proliferate in response to IL-23 alone, and IL-23 did not 
potentiate their anti-CD3/CD28 Ab  –  induced prolifera-
tion. Thus, it is probable that IL-23 is not important for hu-
man Th17 expansion, but rather for their survival and/or 
maintenance. In contrast, under the same conditions, anti-
CD3/28  –  stimulated Th17 and Th17/Th1 clones proliferated 
in response to IL-2, -12, or -15. The ability of IL-2 to pro-
mote the proliferation of human Th17, a fi  nding that was 
also supported by the observation that IL-2 was the growth 
factor used in this study to expand Th17 from both PB or 
  Figure 8.     Effects of IL-12 on ROR     t and T-bet expression and on IFN-      and IL-17 production by Th17 clones. (A) Decreased ROR    t  and 
increased T-bet mRNA expression in fi  ve Th17 clones after stimulation for 7 d with anti-CD3 plus anti-CD28 Ab and IL-2, in the absence (black) or presence 
(gray) of IL-12. a versus b, P       0.05; c versus d, P       0.05. (B) Decreased IL-17 and increased IFN-      mRNA levels in Th17 clones cultured under the condi-
tions described in A. Columns represent mean values (      the SEM). a versus b, P       0.01; c versus d, P       0.01. (C) Reduced levels of IL-17 and increased 
levels of IFN-      in supernatants of Th17 clones, as measured by ELISA. a versus b, P       0.05; c versus d, P       0.001. (D) Decreased proportions of IL-17  –
  producing and increased proportions of IFN-       –  producing cells in response to PMA plus ionomycin by Th17 clones. a versus b, P       0.05; c versus d, 
P       0.05. (E) Flow cytometric analysis of IL-17 and IFN-      production by one representative Th17 clone.     JEM VOL. 204, August 6, 2007 
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portant role of IL-17  –  producing cells in the maintenance of 
the infl  ammatory processes in autoimmune disorders. 
  The receptor expression and functional capabilities ob-
served in T cell clones derived from the aff  ected areas of gut 
from subjects with CD were neither related to their patho-
logical source nor to some in vitro artifact referable to the 
cloning procedure. Indeed, similar receptor expression and 
function were found in T cell clones derived from healthy 
gut areas of subjects who underwent colectomy because of 
colon carcinoma. More importantly, the existence of Th17 
and Th17/Th1 cells, as well as their expression of CCR6, 
IL-23R, and ROR     t was also observed in freshly derived 
CD4  T cells from gut, PB, and tonsil. In this respect, it is 
of note that sorting of CCR6  cells allowed to obtain popu-
lations strongly enriched in IL-17  –  producing cells, suggesting 
that this marker may be useful to get high numbers of Th17 
cells and, therefore, of potentially great help in clarifying 
their pathophysiologic role in humans. Of note, during the 
revision process of this paper, a study was published (  40  ) that 
also reports preferential expression of CCR6 and ROR     t by 
human PB Th17 cells. 
  Another important fi  nding emerging from this study 
was the apparent discrepancy with some results reported in 
mice in regard to the relationship between Th17 and Th1. 
In a fi  rst proposed mouse model, it was suggested that the 
early diff  erentiation of Th1 and Th17 from naive CD4+ T 
cell precursors was shared, and thus Th1 and Th17 diverged 
contingent upon the selective availability of IL-12 or -23 
acting on a common   “  Th1 precursor  ”   or   “  pre-Th1  ”   inter-
mediate that coexpressed IL-12R and -23R (  41  ). However, 
in a subsequently proposed mouse model, which was based 
on the demonstration that the diff  erentiation into Th17 de-
pends upon TGF-      and IL-6 rather than upon IL-23, it was 
suggested that Th1 and Th17 subsets were not overlapping 
and represented distinct lineages (  19, 20  ). In this study, we 
do not provide any evidence for the mechanisms responsi-
ble for the diff  erentiation of human Th17, as well as for the 
question of whether in humans, as in mice, Th17 and Th1 
represent distinct lineages. However, we not only demon-
strated the ex vivo existence of CD4  T cells able to pro-
duce both IL-17 and IFN-      but we were also able to induce 
Th17 clones to produce IFN-      in addition to IL-17 after 
their culturing in the presence of IL-12. The possible rela-
tionship between human Th17 and Th1 was also supported 
by the demonstration that Th17 clones expressed not only 
ROR     t, a fi  nding that is in agreement with the results re-
ported in mice (  21  ), but also remarkable amounts of the 
Th1 transcription factor T-bet, and that amounts of both 
T-bet and ROR     t were comparable in human Th17 and 
Th17/Th1 clones. 
  Interestingly, the ability of IL-12 to induce Th17 cells to 
produce IFN-     , in addition to IL-17 associated with the up-
regulation of T-bet and the down-regulation of both ROR     t 
expression and IL-17 production in Th17 clones. This means 
that in humans, even established Th17 clones, independent 
of whether they have a distinct or common origin with Th1, 
have important implications for the long-term maintenance 
of Th17 infl  ux, supporting their important pathogenic role 
into the infl  amed tissues. 
  Human Th17 and Th17/Th1 clones also shared some 
peculiar functional properties. We found that both types of 
clones were able, as Th1 clones, to provide B cell help for the 
production of IgM, IgG, and IgA, but not IgE, Ab. In contrast, 
as Th2 clones, they showed poor granzyme A expression and 
low cytotoxic capability, thus displaying an intermediate func-
tional pattern in regard to B cell helper and cytotoxic activity 
between Th1 and Th2 clones. However, the most impressive 
functional feature of both Th17 and Th17/Th1 clones was 
their lower susceptibility, in comparison with both Th1 and 
Th2 clones, to the suppressive activity of an autologous T reg 
cell clone derived from circulating CD4 CD25highFoxp3  
cells. Although the mechanism for the higher resistance of 
Th17 and Th17/Th1 to the action of T reg cells is still un-
clear, this fi  nding can provide additional support for an im-
  Figure 9.     IL-23 partially inhibits the increase of IFN-      production 
and the proliferation induced by IL-12 on Th17 clones. (A) Detection 
of IFN-      into cell-free supernatants of Th17 and Th1 clones cultured for 
7 d with anti-CD3/CD28 and IL-2 (black), plus IL-12 (gray), -23 (white), 
or -12 plus -23 (striped). Columns represent mean values (      the  SEM) 
obtained in three different Th17 and in three different Th1 clones. a versus b, 
P       0.05; b versus c, P       0.05; d versus e, P       0.05; e versus f, P       0.05. 
(B) Flow cytometric analysis of IL-17 and IFN-      production by one 
representative Th17 clone, and of its proliferation, as assessed by CFDA-
SE content. Similar results were obtained in other two Th17 clones.     1858 HUMAN T  H  17 CELLS | Annunziato et al.
ported in studies performed in mice (  42, 43  ). Second, T-bet 
has been found to be required for optimal IL-17 production 
in the presence of IL-23 (  44  ). Finally, therapeutic admin-
istration of a small interfering RNA specifi  c for T-bet sig-
nifi  cantly improved the clinical course of established EAE 
by limiting the diff  erentiation of autoreactive Th1 and in-
hibiting pathogenic Th17 via regulation of IL-23R (  45  ). 
These fi  ndings suggest that even in mouse models T-bet and 
ROR     t may play distinct, yet complementary, roles in the 
development of Th17 cells. In this study, the IL-12  –  induced 
IFN-      production by Th17 clones was partially inhibited by 
the contemporaneous presence of IL-23. Because a similar 
inhibitory eff  ect by IL-23 on the IL-12  –  induced IFN-      pro-
duction could also be observed in Th1 clones, which do not 
express IL-23R, it is reasonable to suggest that it was mediated 
by the ability of IL-23 to bind both IL-23R and IL-12R     1 
are responsive to IL-12 and are still suffi   ciently fl  exible to ac-
quire the ability to produce IFN-     . These fi  ndings strongly 
suggest that in human Th17 both ROR     t and T-bet can 
play an important modulatory role. The possibility that T-bet  – 
dependent signaling was responsible for the increased pro-
duction of IFN-      by our T cell clones was not directly explored 
in this study, and thus remains unproved. However, it has re-
cently been shown that ectopic T-bet expression in mouse 
Th17 cells can promote IFN-      secretion and decrease IL-17 
production, suggesting that even in mice the Th17 pheno-
type is not stable and can give rise to IFN-      production in 
vitro via T-bet  –  mediated signaling (  42  ). In this respect, it 
should be taken into account that other recent data in mice, 
again, raise the question of the developmental relationship 
between Th1 and Th17. First, the existence of a dual popula-
tion of IL-17- and IFN-       –  producing cells has also been re-
  Figure 10.     Th17 clones derived from normal gut, as well as freshly derived IL-17  –  producing CD4 T cells, exhibit similar features to gut 
CD-derived Th17 clones. (A) CCR6, IL-23R, and ROR     t mRNA expression by Th1, Th17, and Th17/Th1 clones derived from normal gut of subjects who 
underwent colectomy because of colon carcinoma. Columns represent mean values (      the SEM) obtained from fi  ve clones of each type. (B) Detection of 
IL-17 and IFN-      production by CCR6-depleted and CCR6-enriched CD4  T cell populations from PB or tonsil (top). Measurement of IL-23R and ROR    t 
mRNA levels in CCR6-depleted (black columns) and CCR6-enriched (red columns) CD4  T cells from PB (left) or tonsils (right). Columns represent mean 
values       the SEM were obtained in three different donors of PB or tonsil.     JEM VOL. 204, August 6, 2007 
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  Immunomagnetic cell sorting.     Separation of CCR6  from CCR6      PB 
or tonsillar CD4  T cells was performed by immunomagnetic cell sorting, 
as previously described (  49  ). 
  T cell expansion and cloning.     Gut-derived and PB T lymphocytes were 
expanded by stimulation for 10 d with 5      g/ml anti-CD3 plus 5      g/ml anti-
CD28 mAb (BD Biosciences) and 20 UI/ml IL-2 (Eurocetus). On day 10, T 
cell blasts were cloned under limiting dilution (0.3 cell/well), as previously 
reported (  50  ). T reg clones were generated from CD4 CD25 Foxp3  T 
lymphocytes obtained from PBMC of one subject with CD. To this end, DCs 
were generated from CD14+ cells cultured for 5 d with IL-4 and GM-CSF. 
CD4 CD25      or CD25high T cells were obtained from PBMC by cell sort-
ing. CD4 CD25high cells were cultured with autologous DCs (1:1 ratio) and 
100 U/ml IL-2 for 10 d and cloned under limiting dilution (0.3 cell/well). 
  RNA isolation, cDNA synthesis, and real-time quantitative RT-
PCR.     Total RNA was extracted by using the RNeasy Micro kit (QIAGEN) 
and treated with DNase I to eliminate possible genomic DNA contamina-
tion. Taq-Man RT-PCR was performed, as described elsewhere (  51  ). Prim-
ers and probes used were purchased from Applied Biosystems. 
  Proliferation assay.     5       10  4   total T cell blasts from each clone were stimu-
lated with 2      g/ml anti-CD3 plus 2      g/ml anti-CD28 mAb (BD Bio-
sciences), in the absence or presence of diff  erent cytokines (rIL-2, 50 IU/ml; 
rIL-12, 2.5 ng/ml; rIL-15, 7 ng/ml; rIL-23, 20 ng/ml). In T cell suppression 
experiments, 2       10  4   T cell blasts from Th1, Th2, Th17, or Th1/Th17 clones 
were cultured with 4       10  4   irradiated (9,000 rad) T cell-depleted allogeneic 
PBMC, with or without 2       10  4   T cell blasts from a CD4+CD25  high  Foxp3+ 
T clone. Cultures were pulsed for the last 8 h with 0.5      Ci (0.0185 MBq) 
of   3  H-TdR (GE Healthcare), harvested, and radionuclide uptake was mea-
sured by scintillation counting. In some experiments, cells were labeled with 
CFDA-SE (Invitrogen), as previously described (  52  ). 
  Calcium infl  ux.     5       10  5   cells from a Th1 and a Th17 clone were incu-
bated in complete medium in the presence of 2.5      M Fluo-4 AM (Invitro-
gen) for 30 min in the dark at room temperature. After dye loading, cells 
were washed twice in complete medium and incubated at 37  °  C in the pres-
ence of 5% CO  2   for an additional 30 min. Cells were analyzed by a BD-LS-
RII fl  ow cytometer using the Diva software (Becton Dickinson). The basal 
fl  uorescence intensity was assessed before the stimulus. The stimulation was 
obtained in presence of medium alone or in the presence of 1      g/ml CCL20, 
1      g/ml CCL25, or 1      M ionomycin. 
  B cell helper activity.     2       10  5   human B cells, isolated as CD19+ cells by 
immunomagnetic cell sorting (  49  ), were stimulated with 10  5   Th1, Th2, 
Th17, or Th1/Th17 blasts stimulated with 100 ng/ml anti-CD3 Ab. On day 
7, supernatants from each cell culture were collected and evaluated by ELISA 
for IgM, IgG, IgA, and IgE content. 
  Flow cytometric detection of granzyme A and evaluation of cell 
cytotoxicity.     Granzyme A expression by Th1, Th2, Th17, or Th17/Th1 
clones was assessed according to the manufacturer  ’  s instructions (BD Bio-
sciences). Th1, Th2, Th17, and Th1/Th17 cell clones were tested for their 
ability to kill P815 target cells upon anti-CD3 mAb activation (5      g/ml) by 
evaluating the percentage of AnnexinV-binding cells with fl  ow cytometry, 
as described elsewhere (  52  ). 
  Statistics.     Statistical comparison between groups was performed using the 
Mann-Whitney test or the Wilcoxon test, as appropriate. Diff  erences were 
considered as statistically signifi  cant when P       0.05. 
  The experiments reported in this paper were performed with grants from the 
Associazione Italiana Per La Ricerca Sul Cancro, the Ministero dell  ’  Istruzione, 
dell  ’  Universit  à   e della Ricerca, the Italian Ministry of Health, and FP6 European 
Union project INNOCHEM, LSHB-CT 2500-518157. 
via the p40 chain shared between IL-12 and -23, which there-
fore display binding competition. Because IFN-      is a well 
known inducer of IL-12R     2 (  46  ), it can strongly infl  uence 
the susceptibility of Th17 to the activity of IL-12, thus favor-
ing the shifting of these cells toward the Th1 phenotype. This 
fi  nding may also account for the reported inhibitory activity 
of IFN-      on the development of mouse Th17, as well as for 
its protective eff  ects (  47  ). 
  In conclusion, our data provide the fi  rst detailed pheno-
typic and functional characterization of human Th17 isolated 
from the disease-aff  ected gut mucosa of subjects with CD, 
as well as from normal tissues, showing that Th17 display 
distinct functional properties from Th1 or Th2 cells and identi-
fying IL-23R, CCR6, and ROR     t as Th17  –  specifi  c markers. 
In addition, we describe a new subset of IFN-       –  producing 
Th17 sharing features with both Th1 and Th17, which has 
not been previously reported in mice. This novel subset ex-
ists in vivo in humans and can be induced in vitro by stim-
ulating Th17 in presence of IL-12, thus raising new issues 
on the Th17 developmental and/or functional relationship 
with Th1. 
    MATERIALS AND METHODS   
  Subjects.     Small bowel specimens were obtained from the apparently healthy 
areas of 10 subjects who underwent surgery because of colon cancer, the 
disease-aff  ected areas of 10 subjects with CD, and the disease-aff  ected areas 
of 5 subjects with ulcerative colitis. PB samples were obtained from the 10 
subjects with CD and from 13 healthy donors. Tonsillar specimens were ob-
tained from three children, who were subjected to tonsillectomy because they 
were aff  ected by chronic tonsillitis. The procedures followed in the study 
were in accordance with the ethical standards of the Regional Committee on 
Human Experimentation. 
  Reagents.     The medium used was RPMI 1640 (Seromed) supplemented 
with 2 mM L-glutamine, 1% nonessential amino acids, 1% pyruvate, 2       
10   5   M 2-mercaptoethanol (2-ME; all from Invitrogen), and 10% FCS. 
FITC-, PE-, allophycocyanin-orperidin chlorophyll protein  –  conjugated 
anti-CD3, CD4, CD8, CD25, CD45RA, CD45RO, TCR          , TCR          , 
IFN-     , IL-4, and isotype-matched control mAbs were purchased from BD 
Biosciences. Anti  –  IL-17 and -Foxp3 mAbs were obtained from eBioscience. 
PMA, ionomycin, and brefeldin A were purchased from Sigma-Aldrich. 
Anti-CCR6 mAb was from R  &  D Systems. Anti-ROR     t rabbit polyclonal 
Ab was purchased from Abcam. Anti  –  T-bet rabbit polyclonal Ab was from 
Santa Cruz Biotechnology. 
  T cell recovery.     For isolation of T lymphocytes, epithelial gut layer was 
removed by calcium- and magnesium-free PBS, supplemented with 1 mM 
EDTA and 1 mM DTT (Sigma-Aldrich). Fragments were mechanically dis-
rupted with a MEDI machine (BD Biosciences). MCs were then separated 
from the other cells by Ficoll-Hypaque gradient centrifugation. PBMC and 
tonsil mononuclear cell suspensions were also obtained by centrifugation on 
Ficoll-Hypaque gradient. 
  Flow cytometry.     Analysis of cytokine synthesis at the single-cell level was 
performed as previously reported (  48  ). Foxp3 fl  ow cytometric determination 
was performed according to the manufacturer  ’  s instructions (eBioscience). 
  Confocal microscopy.     Detection of ROR     t and T-bet protein in Th17 
and Th1 clones was performed by confocal microscopy, by using a previ-
ously described technique (  49  ). 1860 HUMAN T  H  17 CELLS | Annunziato et al.
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